Asian Phytoceuticals PCL (BKK: APCO)

Asian Phytoceuticals PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jan 1, 2020
Revenue	249.32	292.76	250.38	223.35	247.73	247.65
Revenue Growth (YoY)	-13.63%	16.93%	12.10%	-9.84%	0.03%	-33.04%
Cost of Revenue	50.3	57.25	47.94	46.26	52.87	51.81
Gross Profit	199.03	235.52	202.44	177.09	194.85	195.85
Selling, General & Admin	116.2	119.72	116.49	106.29	124.73	130.96
Other Operating Expenses	-1.04	-1.09	-2.08	-3.03	-5.41	-0.69
Operating Expenses	115.16	118.63	114.41	103.27	119.32	130.27
Operating Income	83.87	116.89	88.03	73.82	75.53	65.58
Interest Expense	-1.37	-0.66	-0.57	-0.86	-0.48	-
Interest & Investment Income	15.09	15.22	12.41	10.31	4.41	4.64
Earnings From Equity Investments	1.69	1.26	0.61	-0.28	-0.01	0.79
EBT Excluding Unusual Items	99.27	132.72	100.48	82.98	79.45	71.01
Gain (Loss) on Sale of Investments	-0.17	0.47	-0.01	2.51	7.61	1.35
Pretax Income	99.1	133.18	100.47	85.49	87.07	72.36
Income Tax Expense	17.5	24.45	19.28	16.79	17.09	14.45
Earnings From Continuing Operations	81.61	108.74	81.2	68.7	69.98	57.9
Minority Interest in Earnings	-0.96	-1.24	-0.28	-	-	-
Net Income	80.65	107.49	80.92	68.7	69.98	57.9
Net Income to Common	80.65	107.49	80.92	68.7	69.98	57.9
Net Income Growth	-23.95%	32.84%	17.78%	-1.82%	20.85%	-38.88%
Shares Outstanding (Basic)	602	600	600	600	600	600
Shares Outstanding (Diluted)	602	600	600	600	600	600
Shares Change (YoY)	0.23%	0.00%	-0.03%	-0.02%	0.01%	1.33%
EPS (Basic)	0.13	0.18	0.13	0.11	0.12	0.10
EPS (Diluted)	0.13	0.18	0.13	0.11	0.12	0.10
EPS Growth	-24.12%	32.84%	17.82%	-1.80%	20.83%	-39.69%
Free Cash Flow	80.49	120.72	99.86	83.22	82.57	70.51
Free Cash Flow Per Share	0.13	0.20	0.17	0.14	0.14	0.12
Dividend Per Share	0.180	0.180	0.155	0.123	0.120	0.095
Dividend Growth	16.13%	16.13%	25.61%	2.83%	26.32%	-38.67%
Gross Margin	79.83%	80.45%	80.85%	79.29%	78.66%	79.08%
Operating Margin	33.64%	39.93%	35.16%	33.05%	30.49%	26.48%
Profit Margin	32.35%	36.72%	32.32%	30.76%	28.25%	23.38%
Free Cash Flow Margin	32.28%	41.24%	39.88%	37.26%	33.33%	28.47%
EBITDA	90.43	123.69	94.84	81.48	87.51	79.04
EBITDA Margin	36.27%	42.25%	37.88%	36.48%	35.32%	31.91%
D&A For EBITDA	6.57	6.8	6.81	7.66	11.97	13.46
EBIT	83.87	116.89	88.03	73.82	75.53	65.58
EBIT Margin	33.64%	39.93%	35.16%	33.05%	30.49%	26.48%
Effective Tax Rate	17.65%	18.36%	19.19%	19.64%	19.63%	19.97%

Source: S&P Capital IQ. Standard template. Financial Sources.